| TRAW Market Cap History Table | ||||||||||||||||||||||||
Below is a table of the TRAW market cap history going back to 5/1/2024:
Also see: TRAW Shares Outstanding History and TRAW YTD Return |
As of 5/12/2026 Traws Pharma has a market cap of 25.45 million. Investors often follow the TRAW market cap history to compare the size of the company over time.
This page shows TRAW market capitalization trends over time, with 11 market cap datapoints presented, dating back to 5/1/2024.

| TRAW Market Cap History Table | ||||||||||||||||||||||||
Below is a table of the TRAW market cap history going back to 5/1/2024:
Also see: TRAW Shares Outstanding History and TRAW YTD Return |
| TRAW Market Cap History Chart | |||||||||||||||||||||||||||||||||
TRAW Historical Market Cap: +23.08% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||
| TRAW Stock Price Chart |
| About Traws Pharma Inc |
| Traws Pharma, Inc., formerly Onconova Therapeutics, Inc., is a virology and oncology company. Co. is engaged in developing antivirals for influenza, COVID and other respiratory infections and narazaciclib. Its proprietary portfolio includes, TRX100 (viroksavir), TRX01 (travaltrevir), and Narazaciclib. Viroksavir is a cap-dependent endonuclease inhibitor for influenza. Travaltrevir is a Mpro protease inhibitor for COVID19. Narazaciclib is a cyclin-dependent kinases (CDK) 4/6 inhibitor for low-grade endometrioid endometrial cancer (LGEEC). We show 11 historical shares outstanding datapoints in our TRAW shares outstanding history coverage, used to compute TRAW market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing TRAW market cap history over the course of time is important for investors interested in comparing TRAW's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of TRAW versus a peer is one thing; comparing TRAW market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like TRAW can fluctuate over the course of history. With this page we aim to empower investors researching TRAW by allowing them to research the TRAW market cap history. |
| TRAW Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| TRAW Share Performance |
| Market Cap Peers |
| Traws Pharma (TRAW) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
TRDA Market Cap History TRML Market Cap History TROV Market Cap History TRVI Market Cap History TRVN Market Cap History TSBX Market Cap History TSHA Market Cap History TSRO Market Cap History TSVT Market Cap History TTNP Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.